Clostridioides difficile is a type of bacteria that often affects people who have been taking antibiotics, GST Micro LLC ...

Purpose The pharmacology, clinical efficacy, safety, dosage and administration, and place in therapy of fidaxomicin for the treatment of Clostridium difficile infection (CDI) are reviewed.

Patients suffering from a recurrent infection with the C difficile bacteria have benefited from a microbiome treatment from Rebiotix. The results from the open label phase 2 trial confirm that ...

They’ll do tests to see if you have a C. diff infection and provide treatment if needed. Dizziness is a possible side effect of Augmentin. Though not reported in studies, this side effect was ...

Mild Clostridium difficile infection (CDI; stool frequency <four ... and place on therapy immediately if this occurs. Treatment for an initial episode and a first recurrence of CDI: If oral ...

The ongoing trial is testing the therapy – RBX2660 – as a treatment for Clostridioides difficile infection or C. diff, a bacterium that causes diarrhoea and inflammation in the colon and is a ...

difficile infection will likely get it again. There are currently no C. difficile vaccines available, and the main treatment ...

The findings suggest that doctors may be able to save patients from the infections—a plague for hospitals and nursing ...

Ibezapolstat is a small molecule commercialized by Acurx Pharmaceuticals, with a leading Phase II program in Clostridioides difficile Infections (Clostridium difficile Associated Disease).